Cannabis Clinical Trials

The Drug Enforcement Administration’s decision last week not to reschedule marijuana highlights the absurdities of its pre-election limbo. Marijuana will remain a Schedule I drug, meaning that the federal government doesn’t recognize any of its medical uses and considers it to have high potential for abuse. “This decision isn’t based on danger,” DEA chief Chuck […]

by

Study by Columbia University is the first to test theory in humans Researchers found men felt less pain after consuming cannabis It comes amid widespread push to legalize medical marijuana  By Mia De Graaf For Dailymail.com Published: 15:50 EST, 18 August 2016 | Updated: 15:50 EST, 18 August 2016 … read more at: http://www.dailymail.co.uk/health/article-3747847/Cannabis-better-painkiller-MEN-women-study-claims.html

by

NEW YORK, NY (August 18, 2016)–Researchers from Columbia University Medical Center (CUMC) found that men had greater pain relief than women after smoking marijuana. Results of the study were recently published online in Drug and Alcohol Dependence. “These findings come at a time when more people, including women, are turning to the use of medical […]

by

Image source: Getty Images. Earlier this year, GW Pharmaceuticals (NASDAQ:GWPH) stock rallied on clinical success with its cannabis-derived epilepsy treatment. After falling more than 40% in the first months of 2016, the volatile marijuana stock is up about 16% year to date. After the recent run-up, there are a few reasons to believe GW Pharmaceuticals could rise […]

by

Six days before Prince died, the iconic pop star was hospitalized after possibly overdosing on Percocet. His death on April 21 involved overdosing on another painkiller, fentanyl. Both are among the prescription opioids that alleviate the pain of millions of Americans every year—often at the price of their needing ever greater amounts and the risk […]

by

ANDERSON – The Drug Enforcement Administration recently announced it won’t reclassify marijuana as a Schedule II drug, but it did make one change that will allow more research on the drug’s medicinal properties. Schedule I drugs are the most dangerous drugs as deemed by the DEA, do not currently have any medical use and have […]

by

Perth, Aug 15, 2016 AEST (ABN Newswire) – MMJ PhytoTech Limited (ASX:MMJ) (“MMJ” or “the Company”) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited (“PTL”), will commence a Phase 2 clinical study into the efficacy of the its PTL101 capsules in treating intractable epilepsy in children. Highlights: – Phase 2 clinical […]

by

MMJ PhytoTech Limited (ASX:MMJ) (“MMJ” or “the Company”) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited (“PTL”), will commence a Phase 2 clinical study into the efficacy of the its PTL101 capsules in treating intractable epilepsy in children. Highlights: – Phase 2 clinical trial of PTL101 capsules to commence Q4 2016 […]

by

At least once a week, Steve McDonald drives from his home in Irvine to an industrial stretch of Santa Ana filled with auto shops and home-improvement wholesalers. Inside a beige storefront, McDonald consults with young budtenders about the jars of raw cannabis flowers and rows of infused edibles that fill the shelves at From the […]

by